Trade Summary

Yesterday, Lucera Erick, serving as CFO at Dyne Therapeutics, Inc. (DYN), sold 1,448 shares at $18.36 per share, for a total transaction value of $26,585.00. Following this transaction, Lucera Erick now holds 123,925 shares of DYN.

This sale represents a 1.00% decrease in Lucera Erick's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, May 13, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 14, 2026 at 4:03 PM ET, 1 day after the trade was made.

Dyne Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.